Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells

scientific article published on 10 February 2014

Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/1547691X.2014.880533
P698PubMed publication ID24512329

P50authorBenjamin FreyQ38326649
Niels SchaftQ43193257
Jan DörrieQ46174669
Lisa DelochQ59817017
Rainer FietkauQ64584867
P2093author name stringUdo S Gaipl
Yvonne Rubner
Lorenz Kulzer
Andrea Allgäuer
P2860cites workCombining radiotherapy and cancer immunotherapy: a paradigm shiftQ27021428
Dendritic cells and the control of immunityQ27860918
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunityQ28304923
Anti-tumor immunity: myeloid leukocytes control the immune landscapeQ28390573
Dendritic cells: specialized and regulated antigen processing machinesQ29617085
Functional diversity of helper T lymphocytesQ29619415
Immunologic correlates of the abscopal effect in a patient with melanomaQ29620334
Transforming growth factor-beta activation in irradiated murine mammary glandQ34128453
Cytokine patterns in patients with cancer: a systematic review.Q34342581
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapyQ34949098
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyQ35540109
Cytometric bead array: a multiplexed assay platform with applications in various areas of biologyQ35718665
Radiation-induced cell death and dendritic cells: potential for cancer immunotherapy?Q36044123
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatmentQ37268974
CD25 as an immune regulatory molecule expressed on myeloid dendritic cellsQ37300261
In vitro assays of allosensitizationQ37328591
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibodyQ37351567
Systemic effects of local radiotherapyQ37539309
Harnessing dendritic cells in cancerQ37835970
Radiobiological rationale and clinical implications of hypofractionated radiation therapy.Q37868153
How does ionizing irradiation contribute to the induction of anti-tumor immunity?Q38030920
American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) practice guideline for the performance of total body irradiation (TBI).Q38075441
Tumor-altered dendritic cell function: implications for anti-tumor immunityQ38123166
Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.Q40144504
A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytesQ40340738
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumorQ40412166
Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytesQ40497215
Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.Q50777089
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectadaptive radiation therapyQ180507
dendritic cellQ506253
P304page(s)328-336
P577publication date2014-02-10
P1433published inJournal of ImmunotoxicologyQ6295320
P1476titleNorm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells
P478volume11

Reverse relations

cites work (P2860)
Q58701245Alterations of MicroRNA Expression in the Liver, Heart, and Testis of Mice Upon Exposure to Repeated Low-Dose Radiation
Q39203685Barriers to Radiation-Induced In Situ Tumor Vaccination.
Q55316979Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.
Q51551651Cancer Cell Death-Inducing Radiotherapy: Impact on Local Tumour Control, Tumour Cell Proliferation and Induction of Systemic Anti-tumour Immunity.
Q90629204Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Q87827392Exploring the rationale for combining ionizing radiation and immune checkpoint blockade in head and neck cancer
Q33751085Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation.
Q92741127Immune biological rationales for the design of combined radio- and immunotherapies
Q38641806Immune-modulating properties of ionizing radiation: rationale for the treatment of cancer by combination radiotherapy and immune checkpoint inhibitors
Q48193685Immunomodulation by ionizing radiation-impact for design of radio-immunotherapies and for treatment of inflammatory diseases.
Q39389306Intercellular Communication of Tumor Cells and Immune Cells after Exposure to Different Ionizing Radiation Qualities
Q64943265Key mechanisms involved in ionizing radiation-induced systemic effects. A current review.
Q35909590Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study
Q26744490Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation
Q39365749Modulating Both Tumor Cell Death and Innate Immunity Is Essential for Improving Radiation Therapy Effectiveness
Q60938469Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer
Q60956725Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
Q26779221Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications
Q38981347Rationale and evidence to combine radiation therapy and immunotherapy for cancer treatment
Q48310789Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer.
Q57146748Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Q89475171Synergistic effect of cisplatin chemotherapy combined with fractionated radiotherapy regimen in HPV-positive and HPV-negative experimental pharyngeal squamous cell carcinoma
Q37625801The Immunoregulatory Potential of Particle Radiation in Cancer Therapy
Q36069982The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
Q26783291The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy

Search more.